Biological Function and Catalyzed Reactions
In the human body, xanthine oxidase plays a critical role as the final link in the purine degradation chain. Its main task is to transform intermediate nitrogenous metabolites into a final product for subsequent excretion.
The process proceeds in two strictly irreversible steps:
- First, the enzyme oxidizes hypoxanthine, converting it into xanthine.
- Then, a secondary oxidation occurs — xanthine is transformed into uric acid.
It is worth noting that the enzyme does not possess absolute substrate specificity. It exhibits group specificity: in addition to purine bases (hypoxanthine and xanthine), it can oxidize certain aldehydes. This makes it an important participant in the detoxification of various compounds.
Mechanism of Action: Oxygen and By-products
From a biochemical classification standpoint, xanthine oxidase is an aerobic dehydrogenase. Molecular oxygen ($O_2$) is vital for the enzyme to carry out oxidation-reduction reactions.
During the catalytic act, electrons are transferred directly to the oxygen molecule. This process inevitably leads to the generation of reactive oxygen species. Hydrogen peroxide ($H_2O_2$) and superoxide anion are synthesized as by-products. Because of this feature, the enzyme is considered a significant cellular source of oxidative stress.
Structure and Active Center Cofactors
To accomplish the complex multi-step electron transfer to oxygen, xanthine oxidase requires a rich set of cofactors. Its active center necessarily includes:
- FAD (flavin adenine dinucleotide), a vitamin B2 derivative;
- Molybdenum (Mo), a trace element rare in the body that plays a key role in substrate binding;
- Iron-sulfur clusters (Fe-S), structures that provide intermediate electron transport.
An important nuance for students: unlike many other dehydrogenases, xanthine oxidase does not contain $NAD^+$ (a vitamin PP derivative). Attributing NAD to this enzyme is a common mistake.
Clinical Significance: Link to Gout
The activity of xanthine oxidase is directly linked to the development of conditions such as gout. The reason lies in the physicochemical properties of the substrates and reaction products.
The initial metabolite, hypoxanthine, is highly soluble in water and moves easily in biological fluids. However, the final oxidation product, uric acid, has extremely poor solubility. If enzyme activity is elevated or uric acid excretion is impaired, it begins to crystallize in tissues and synovial joint fluid. The precipitation of uric acid crystals triggers the severe inflammatory process characteristic of gout attacks.